Athenahealth fields multiple bids and more news from other sources

Technology

Athenahealth fields multiple bids, but offers not much higher than current stock price, sources say | CNBC

The Athenahealth board is eager to make a deal, according to sources that spoke with CNBC. The interested parties are two private equity firms and one strategic buyer. Athenahealth has already rejected one bid, from Elliott Management for $160 a share.

Oculus, VRHealth partner to develop VR pain management, anxiety management therapies | Mobihealthnews

Facebook-backed Oculus and VRHealth will work together for pain management tools for women in labor and for patients undergoing chemotherapy. They'll also develop a tool for pre- and post-operative anxiety.

Pharmaceuticals

Pay-to-delay deals for biosimilars may be hard to pull off under a newly passed bill | Stat

The Patient Right to Know Act would require manufacturers of biologics and biosimilars to report patent litigation settlements to the Department of Justice and Federal Trade Commission.

Medical devices

Aiming to revolutionize medical ultrasound, Butterfly raises $250 million at a $1.25 billion valuation | Forbes

Butterfly makes the iQ, a $2000 handheld ultrasound device. The company expects "thousands" of the devices to be in use by the end of the year.

In other news

Tesla chief Elon Musk is sued by SEC in move that could oust him | The New York Times

Federal regulators accused Musk of fraud when he falsely stated on Twitter that he had secured funding to buy out stock of Tesla, thereby misleading investors.